Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial ribosomal protein S33 pseudogene 2 (MRPS33P2) is a processed pseudogene, meaning it is a non-functional genomic remnant of the MRPS33 gene, which encodes a protein component of the small 28S subunit of the mitochondrial ribosome involved in mitochondrial protein synthesis. MRPS33P2 does not encode a functional protein and there is no evidence it acts as a therapeutic target, receptor, enzyme, transporter, or similar molecule. There are no known drugs, disease associations, or defined biological functions for MRPS33P2, but like some pseudogenes, it is theoretically possible it might play a regulatory RNA role through microRNA decoy mechanisms, though this is not established for MRPS33P2 itself. The term \"mitochondrial ribosomal protein S33 pseudogene 2\" refers to a pseudogene, which is not a druggable target, receptor, enzyme, transporter, or similar, and does not have the properties typically sought in molecular target databases. The entry is only a genomic non-coding remnant without established functional, pharmacological, or disease relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial ribosomal protein S33 pseudogene 2 (MRPS33P2).